Maurice Joseph Anthony Clancy

Title: The Innovations of Maurice Joseph Anthony Clancy

Introduction

Maurice Joseph Anthony Clancy is a notable inventor based in Athlone, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. His work has the potential to enhance the therapeutic efficacy of medications, providing patients with improved treatment options.

Latest Patents

Clancy holds a patent for "Controlled release pharmaceutical compositions containing tiagabine." This invention involves controlled release oral pharmaceutical preparations that include a therapeutically effective amount of tiagabine or a pharmaceutically acceptable salt. The formulation is designed to be dispersed in a rate-controlling polymeric matrix, which allows for the sustained release of the drug. The preparation can be formulated into oral dosage forms such as tablets or multiparticulates, ensuring that therapeutic plasma levels of tiagabine are maintained for extended periods, ideally for 24 hours or more.

Career Highlights

Clancy is associated with Elan Corporation, Plc, where he has contributed to various pharmaceutical innovations. His work focuses on enhancing drug delivery systems, which is crucial for improving patient compliance and treatment outcomes. His patent reflects his commitment to advancing pharmaceutical science and improving healthcare.

Collaborations

Clancy has worked alongside notable colleagues, including Kenneth Iain Cumming and Michelle Caulfield. Their collaborative efforts have likely contributed to the success of their projects and innovations within the pharmaceutical industry.

Conclusion

Maurice Joseph Anthony Clancy's contributions to controlled release pharmaceutical compositions demonstrate his innovative spirit and dedication to improving patient care. His work continues to influence the field of pharmaceuticals, paving the way for more effective treatment options.